Mitsubishi Ufj Asset Management (Uk) Ltd. Gilead Sciences, Inc. Transaction History
Mitsubishi Ufj Asset Management (Uk) Ltd.
- $192 Million
- Q3 2024
A detailed history of Mitsubishi Ufj Asset Management (Uk) Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Asset Management (Uk) Ltd. holds 17,000 shares of GILD stock, worth $1.6 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
17,000
Previous 2,000
750.0%
Holding current value
$1.6 Million
Previous $137,000
939.42%
% of portfolio
0.74%
Previous 0.07%
Shares
15 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
992MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.9 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.23 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.83 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.68 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $118B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...